UNIGE document Scientific Article - Meta-analysis
previous document  unige:25529  next document
add to browser collection

Management of chronic hepatitis B: an update

Published in Swiss Medical Weekly. 2011, vol. 141, w13264
Abstract Since the publication in 2009 of clinical practice guidelines for the management of hepatitis B virus (HBV) infection by the European Association for the Study of the Liver (EASL), a wealth of new data has emerged regarding the antivirals most commonly used to treat chronic hepatitis B. This review will summarise the most recent knowledge on these drugs, and how this may affect current and future management of HBV infection. Despite the progress in drug development, HBV infection remains a complex entity, characterised by a peculiar interplay between host and viral factors. With the potent drugs currently available, however, its management and control are possible in the majority of cases.
Keywords Alanine Transaminase/bloodAntiviral Agents/therapeutic useDNA, Viral/bloodHepatitis B Surface Antigens/blood/drug effectsHepatitis B virusHepatitis B, Chronic/blood/drug therapyHumansInterferon-alpha/therapeutic usePractice Guidelines as TopicViral Load/drug effects
PMID: 21913139
Full text
Article (Published version) (429 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research group Etudes et traitement de l'hépatite C et B (554)
(ISO format)
NEGRO, Francesco. Management of chronic hepatitis B: an update. In: Swiss Medical Weekly, 2011, vol. 141, p. w13264. doi: 10.4414/smw.2011.13264 https://archive-ouverte.unige.ch/unige:25529

433 hits

0 download


Deposited on : 2013-01-15

Export document
Format :
Citation style :